Kelly K. Pertile

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Amyloid-β protein precursor fragments in urine: Potential biomarkers for the early detection of mild cognitive impairment and dementia.

Amyloid-β protein precursor fragments in urine: Potential biomarkers for the early detection of mild cognitive impairment and dementia.

Journal: Journal of Alzheimer's disease : JAD

Published: June 24, 2025

Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer's Disease.

Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer's Disease.

Journal: International journal of molecular sciences

Published: June 17, 2022

Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease.

Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 29, 2022

Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β.

Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β.

Journal: Neurobiology of disease

Published: October 24, 2021

Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's disease.

Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's disease.

Journal: Proteome science

Published: September 13, 2021

Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease.

Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease.

Journal: Journal of Alzheimer's disease reports

Published: August 09, 2021

Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.

Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.

Journal: Journal of Alzheimer's disease : JAD

Published: November 25, 2017

Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.

Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.

Journal: Journal of Alzheimer's disease : JAD

Published: September 25, 2015

Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology.

Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology.

Journal: Alzheimer's research & therapy

Published: January 09, 2015

Peripheral α-defensins 1 and 2 are elevated in Alzheimer's disease.

Peripheral α-defensins 1 and 2 are elevated in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: November 20, 2014

An anemia of Alzheimer's disease.

An anemia of Alzheimer's disease.

Journal: Molecular psychiatry

Published: July 20, 2013

Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.

Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: November 22, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026